ID	Internal ID of the variant
Gene	Name of the gene assayed
HGVS_Nucleotide_Variant	HGVS cDNA string specifying the variant
Chromosomal_Variant	Genomic  HGVS string specifying the variant
Result_Findlay	Overall authors' interpretation of the functional impact of the variant, Findlay et al, 2018
Function_Score_Findlay	Score reflecting the impact of the variant on cell survivial, Findlay et al, 2018
RNA_Score_Findlay	Score reflecting the impact of the variant on RNA production, Findlay et al, 2018
RNA_Class_Findlay	Authors' assessment of the impact of the variant on RNA production, Findlay et al, 2018
Result_Starita	Authors' interpretation on the functional impact of the variant, Starita et al, 2018
Control_Group_Petitalot	Indicates whether the variant was part of a control group of either causal or neutral variants, Petitalot et al, 2019
Result_Petitalot	Authors' interpretation of the functional impact of the variant, Petitalot et al, 2019
Selection_Bouwman1	Indicates whether the variant was designated as a neutral control, deleterious control, artificial, or VUS: Bouwman et al, 2013
Result_Bouwman1	Authors' overall interpretation of the functional impact of the variant, Bouwman et al, 2013
Cisplatin_Bouwman2	Impact of the variant on Cisplatin drug sensitivity, Bouwman et al, 2020
Olaparib_Bouwman2	Impact of the variant on Olaparib drug sensitivity, Bouwman et al, 2020
DRGFP_Bouwman2	Impact of the variant in a direct-repeat GFP homologous recombination DNA repair, Bouwman et al, 2020
Result_Bouwman2	Authors' overall interpretation of the functional impact of the variant, Bouwman et al, 2020
Result_Fernandes	Authors' interpretation of the overall functional impact of the variant, Fernandes et al, 2019 
Complementation_Mesman	Indicates whether the variant was able to complement the phenotype induced by loss of endogenous BRCA2, Mesman et al, 2019
HDR_Mesman	Impact of the variant on homolgous DNA repair, Mesman et al, 2019
Cisplatin_Mesman	Impact of the variant to Cisplatin drug sensitivity, Mesman et al, 2019
Result_Mesman	Authors' overall interpretation on the functional impact of the variant, Mesman et al, 2019
HDR_Richardson	Impact of the variant on homolous DNA repair, Richardson et al, 2021
Result_Richardson	Authors' interpretation of the functional impact of the variant, Richardson et al, 2021
Result_Ikegami	Authors' interpretation on the functional impact of the variant, Ikegami et al, 2020
Olaparib_fClass_Ikegami	Impact of the variant on Olaparib drug sensitivity, Ikegami et al, 2020
Niraparif_fClass_Ikegami	Impact of the variant on Nirapaif drug sensitivty, Ikegami et al, 2020
Rucaparib_fClass_Ikegami	Impact of the variant on Rucaparib drug sensitivity, Ikegami et al, 2020
CBDCA_fClass_Ikegami	Impact of the variant on carboplatin (CBDCA) drug sensitivyt, Ikegami et al, 2020
HAT_(Cell_Survival)_Biwas	Impact of the variant on cell survival in the HAT medium, Biwas et al, 2020
DS_(Drug_Sensitivity)_Biwas	Impact of the variant on drug sensitivity, Biwas et al, 2020
HAT+DS_Score_Biwas	Overall score reflecting both cell survival and drug sensitivity, Biwas et al, 2020
Result_Biwas	Authors' interpretation of the functional impact of the variant, Biwas et al, 2020
